General Practitioner Interview Questions: Clinical Reasoning & Patient Care (GP)

In a GP interview, I aim to demonstrate a clear triage-first structure that makes escalation decisions defensible. For time-critical presentations like chest pain, acute breathlessness or suspected sepsis, I start with immediate observations—oxygen saturation, blood pressure, respiratory rate—and I use a rapid ABC-style approach to prioritise threats to life. I then document a focused history and examination, and I trigger the relevant urgent pathway promptly, such as arranging a same-day ECG and emergency bloods including high-sensitivity troponin where indicated. I also apply validated clinical decision support tools where appropriate—for example Wells criteria for suspected pulmonary embolism—and I consider alternative diagnoses that could be immediately life-threatening. Crucially, I ensure my notes in EMIS Web or Best Practice explain the reasoning, include what I considered, and specify exactly what safety-net advice I gave, because that is what teams and supervisors review for quality and patient safety.

For chronic conditions such as type 2 diabetes, hypertension, COPD or atrial fibrillation, interviewers want to hear that you can run structured reviews, not just have supportive conversations. I use guideline frameworks consistent with NICE principles—for diabetes, hypertension and COPD—and I translate them into measurable KPIs that can be tracked over time. Examples include HbA1c targets, annual retinal screening attendance, urine ACR monitoring for kidney risk, BP readings showing control, and spirometry/clinical review cadence for respiratory disease. I schedule follow-ups based on clinical need, such as repeating HbA1c around 3 months after starting or changing therapy until stable, then extending intervals for well-controlled patients. I document treatment discussions and agreed goals using shared decision-making, and I record the rationale for medicine changes and investigations in the clinical system so nothing is lost in handover. In the UK context I may reference QOF-style monitoring; for Australia and New Zealand I describe the analogous performance-driven workflows (practice audits, chronic disease plans and local incentive frameworks) while still individualising targets for age, frailty and patient priorities.

Medicines optimisation is a core GP competency, and interviewers commonly probe whether you can prevent harm through accurate reconciliation and risk-based prioritisation. My approach starts with comparing what is prescribed with what the patient is actually taking, including checking repeat prescription history and the active problem and medicine list within the clinical system (EMIS Web or Docman/Best Practice). I look for common safety issues: duplications, out-of-date medicines, contraindications, renal dosing problems, missed monitoring bloods and clinically significant interactions. When a patient’s record flags missing prescriptions, I assess adherence in a non-judgemental way, exploring barriers like side effects, complex dosing schedules, health beliefs and practical access issues. I consider tools such as dose administration aids, pill organisers and simplified regimens, and I decide what to escalate first based on clinical risk. For infections where antibiotics may be uncertain, I demonstrate stewardship by using clinical assessment, local antimicrobial guidance and a clear review plan—sometimes delayed prescribing—paired with explicit safety-net thresholds and analgesia advice. I also ensure that any prescribing decisions are documented with clear rationale and a monitoring plan so the next clinician can continue safely.

GP consultations often involve emotionally charged decisions, so interviewers assess both communication skills and safeguarding competence. For consent and difficult outcomes, I aim to create psychological safety while maintaining clinical accountability: I explain options in plain language, check understanding with teach-back, and document informed decisions and patient preferences clearly. When safeguarding concerns arise, I describe how I follow structured escalation pathways through the practice safeguarding lead and ensure objective, factual documentation of observations rather than assumptions. In end-of-life discussions, I demonstrate structured communication such as SPIKES or similar principles—asking permission, exploring understanding and sharing information at the patient’s pace. I validate avoidance without forcing details, offering choices about what to discuss now and what can be revisited later, and I focus conversations on goals of care like symptom control and preferred place of care. I also coordinate with community teams and relevant anticipatory medicines where appropriate, then record an emergency plan and review arrangements so the patient’s wishes remain actionable. Finally, I show professionalism with boundaries—using appropriate consultation planning and signposting tools to reduce repeated demand while keeping care consistent.